Sigma-Aldrich recently announced that it has released new additions to its Mission TRC RNAi product line. These additions bring the current number of vector constructs offered to 50,000, targeting 7,100 human and 2,900 mouse genes, the company said.
The constructs are available as frozen bacterial glycerol stocks or transfection grade plasmid DNA, Sigma-Aldrich said.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
